In vitro elimination of antimicrobials during ADVanced Organ Support hemodialysis
BackgroundAcute kidney injury (AKI) requiring continuous renal replacement therapy is common in critically ill patients. The ADVanced Organ Support (ADVOS) system is a novel hemodialysis machine that uses albumin enriched dialysate which allows the removal of protein-bound toxins and drugs. To date,...
Saved in:
| Main Authors: | Christina König, Otto Frey, Susanne Himmelein, Lisa Mulack, Alexander Brinkmann, Aritz Perez Ruiz de Garibay, Tobias Bingold |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1447511/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibacterial therapy of sepsis in extracorporeal detoxication: current problems and ways to solve them
by: A. V. Marukhov, et al.
Published: (2020-12-01) -
Pharmacokinetic Changes and Influencing Factors of Polymyxin B in Different ECMO Modes
by: Xu M, et al.
Published: (2024-12-01) -
The Current State of Renal Replacement Therapy in the Treatment of Sepsis
by: T. G. Kim, et al.
Published: (2021-08-01) -
Antimicrobial Dosing During Continuous Venovenous Hemodiafiltration in Septic Shock Patients: A Prospective, Multicenter Study Protocol
by: Alicia Wendy Vega Harwood, et al.
Published: (2025-04-01) -
CRRT Is More Than Just Continuous Renal Replacement Therapy
by: Lóránd Erdélyi, et al.
Published: (2024-11-01)